[Elsevier] The impact of bioequivalence regulation on pharmaceutical firm outcomes: Evidence from China

vanlong113 Post time 3 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-25 13:38
Reward20points

journalㄩSocial Science & Medicine

AuthorsㄩMenghan Shen; Xiaoxia Liang; Han Wu

Published dateㄩ2025-9-

DOIㄩ10.1016/j.socscimed.2025.118242

PDF linkㄩhttps://www.sciencedirect.com/sc ... 277953625005738/pdf

Article linkㄩhttps://doi.org/10.1016/j.socscimed.2025.118242

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Mango101 Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list